| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CHD.12543 |
| P8608 | Fatcat ID | release_5uel57yea5elnap24ddlqyzysa |
| P698 | PubMed publication ID | 28984030 |
| P50 | author | Andrew D Spearman | Q57103090 |
| P2860 | cites work | Mutations in NOTCH1 cause aortic valve disease | Q24307999 |
| Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy | Q24603793 | ||
| Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects | Q26744645 | ||
| MicroRNA and Heart Failure | Q26750638 | ||
| Novel epigenetic-based therapies useful in cardiovascular medicine | Q26765152 | ||
| The emerging role of epigenetics in cardiovascular disease | Q26852614 | ||
| Epigenetic mechanisms in fetal origins of health and disease | Q26991551 | ||
| Epigenetics: a new mechanism of regulation of heart failure? | Q27013611 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
| Myocardial microRNAs associated with reverse remodeling in human heart failure. | Q42328615 | ||
| Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors | Q44449807 | ||
| Reading signals on the nucleosome with a new nomenclature for modified histones | Q45258400 | ||
| Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. | Q47989181 | ||
| Pleiotropic and Adverse Effects of Statins-Do Epigenetics Play a Role? | Q50961387 | ||
| Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1. | Q51358655 | ||
| miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis. | Q53185427 | ||
| Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy. | Q54168060 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Computational modelling for congenital heart disease: how far are we from clinical translation? | Q28079749 | ||
| CpG-rich islands and the function of DNA methylation | Q28131800 | ||
| Myosin heavy chain isoform expression in the failing and nonfailing human heart | Q28145777 | ||
| Control of stress-dependent cardiac growth and gene expression by a microRNA | Q28587851 | ||
| Functions of DNA methylation: islands, start sites, gene bodies and beyond | Q29547260 | ||
| Functions of site-specific histone acetylation and deacetylation | Q29617894 | ||
| MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure | Q29619548 | ||
| Cardiovascular malformations caused by NOTCH1 mutations do not keep left: data on 428 probands with left-sided CHD and their families. | Q31040681 | ||
| Differential expression of microRNAs following cardiopulmonary bypass in children with congenital heart diseases | Q33742505 | ||
| A Path to Implement Precision Child Health Cardiovascular Medicine | Q33747402 | ||
| Chromatin regulation by Brg1 underlies heart muscle development and disease | Q33969388 | ||
| Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes | Q33998649 | ||
| De novo mutations in histone-modifying genes in congenital heart disease. | Q34344183 | ||
| Micro-RNA expression in hypoplastic left heart syndrome | Q34771702 | ||
| Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation | Q34900192 | ||
| Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries. | Q34990770 | ||
| Epigenetic modifications in cardiovascular disease. | Q35898458 | ||
| Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure | Q35964249 | ||
| Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis | Q36004612 | ||
| MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1. | Q36744018 | ||
| Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pedia | Q36829213 | ||
| The molecular basis of congenital heart disease | Q36993761 | ||
| The developmental genetics of congenital heart disease. | Q37089736 | ||
| MicroRNA regulation of cardiovascular development | Q37148254 | ||
| G9a inhibits MEF2C activity to control sarcomere assembly. | Q37282370 | ||
| NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling | Q37294787 | ||
| Epigenetics in cardiovascular disease | Q37637387 | ||
| Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support | Q37667942 | ||
| Therapeutic potential for HDAC inhibitors in the heart | Q37937667 | ||
| Epigenetics, the missing link in hypertension | Q38240383 | ||
| Translational Perspective on Epigenetics in Cardiovascular Disease | Q38650827 | ||
| Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy | Q38678462 | ||
| Impact of MYH6 variants in hypoplastic left heart syndrome. | Q38803277 | ||
| Therapeutic applications of histone deacetylase inhibitors in sarcoma | Q39450827 | ||
| P433 | issue | 6 | |
| P921 | main subject | epigenetics | Q26939 |
| P304 | page(s) | 828-833 | |
| P577 | publication date | 2017-10-05 | |
| P1433 | published in | Congenital Heart Disease | Q15761142 |
| P1476 | title | Epigenetics for the pediatric cardiologist | |
| P478 | volume | 12 |
| Q61798663 | Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome | cites work | P2860 |
Search more.